Spain· ES:1140940003
TRIUMEQ 5 MG/60 MG/30 MG COMPRIMIDOS DISPERSABLES
A medicinal product containing dolutegravir + abacavir + lamivudina, registered in Spain by Viiv Healthcare B.V..
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- dolutegravir + abacavir + lamivudina
- Manufacturer
- Viiv Healthcare B.V.
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dolutegravir + abacavir + lamivudina in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandTriumeq2care4 ApS
- CzechiaTRIUMEQViiV Healthcare BV, Amersfoort
- SwitzerlandTriumeq, FilmtablettenViiV Healthcare GmbH
- FranceTRIUMEQ 5 mg/60 mg/30 mg, comprimé dispersibleVIIV HEALTHCARE (PAYS-BAS)
- United KingdomTriumeq 50mg/600mg/300mg tabletsViiV Healthcare UK Ltd
- IrelandTriumeq 5 mg/60 mg/30 mg dispersible tabletsViiV Healthcare BV
- IcelandTriumeqViiV Healthcare BV
- NetherlandsTriumeq 5 mg/ 60 mg/ 30 mg dispergeerbare tablettenViiV Healthcare B.V.
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Iceland · Triumeq
- Liechtenstein · Triumeq
- Malta · Dolutegravir/Abacavir/Lamivudine Pharos
- Norway · Triumeq
- Portugal · Dolutegravir/Abacavir/Lamivudine Pharos
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/499a70d0-d809-4356-b72c-18cbbd194a47 GET /v1/drugs/499a70d0-d809-4356-b72c-18cbbd194a47?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Diagnóstico Hospitalario",
"estado": "{\"aut\":1684926770000}",
"nregistro": "1140940003",
"substance": "dolutegravir + abacavir + lamivudina"
}See everything about dolutegravir + abacavir + lamivudina.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.